Sales: $7.1 billion
$7.1 billion for skin, oral and baby care products. Corporate sales: $61.9 billion. Net income: $12.3 billion
William C. Weldon, chairman and chief executive officer; Dominic J. Caruso, vice president, finance and chief financial officer; Stephen J. Cosgrove, corporate controller; Laverne H. Council, vice president, chief information officer; Russell C. Deyo, vice president, general counsel; Colleen A. Goggins, worldwide chairman, consumer group
Aveeno and Neutrogena skin care and sun care products; Clean & Clear teen skin care products;
Johnson & Johnson is a major player in the global skin care market, but medical devices and diagnostics represent more than a third of J&J’s sales. In fact, devices and diagnostics sales even outpace pharmaceutical sales.
Aveeno—Ageless Vitality Elasticity Recharging System, Positively Nourishing body wash and body moisturizer, Nourish & Shine shampoo and conditioner, Positively Ageless sunblock lotion; Johnson’s—Head-to-Toe fragrance-free baby lotion, Baby Bubble bath and wash; Listerine—Total Care; Neutrogena—Clinical anti-aging skin care line, Men Sensitive Skin, Rapid Clear Sore Pimple Gel, SkinClearing Mineral Powder, Spectrum+ Advanced sunblock lotion, RoC—Complete Lift daily moisturizer SPF 30, Complete Lift Eye Pen, Retinol Correxion Deep Wrinkle Filler; Reach—Reach by Design toothbrush collection (August)
Corporate sales fell nearly 3% and even J&J’s normally fast-growing consumer products unit couldn’t outrun the recession as sales dropped 1%. Taking a closer look at Happi’s markets, skin care sales grew 2.5% to $3.5 billion in 2009. The gain was primarily due to the Aveeno, Neutrogena and Dabao skin care lines. Baby care sales fell 4.5% to $2.1 billion, primarily due to the negative impact of currency and lower sales for Babycenter.com as a result of exiting the online retail business. That decline was partially offset by growth in the hair care product line.
The good news is that things started to turn around in 2010. First quarter corporate sales rose 4% to $15.6 billion. Worldwide consumer sales rose 1.5% to $3.8 billion for the first quarter, thanks to sales of Neutrogena, Aveeno, Le Petit Marseillais and Listerine. Skin care sales rose 9.3% to $920 million, baby care sales were up 8.2% to $529 million and oral care sales gained 4.4% to $381 million.